© 2021 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
May 01, 2021
Uwe Oberheide, MD, discusses the key findings of his virtual ARVO 2021 presentation on modeling of IOLs for patients with AMD by ray-tracing.
April 21, 2021
Johnson & Johnson Vision announced today that the FDA has granted 510(k) clearance and CE mark for its VERTIAST Vision System, a next-generation phacoemulsification innovation.
April 11, 2021
Lens offers full range of vision from distance through near vision.
April 09, 2021
New option may prove to be a solution for cataract cases with unusual corneas.
March 14, 2021
Practice and preparation are key for mastering the procedure.
March 13, 2021
One surgeon shares the early results of his experience using the new TECNIS Eyhance and TECNIS Eyhance Toric II IOLs in performing the first post-FDA-approved cases in the U.S.
March 10, 2021
Phakic option provides hope to patients who are not candidates for laser vision correction.
February 15, 2021
To mark the 20th anniversary of its TECNIS IOLs, Johnson & Johnson Vision is launching the “See More” campaign to educate patients and physicians on what is possible with cataract surgery.
February 03, 2021
Daniel H. Chang, MD, shares data on a recent study involving a new violet light-filtering chromophore in a preclinical computer simulation testing and randomized clinical study.
February 02, 2021
Phakic lenses are proving to be excellent additions to refractive practices.
